Breaking News on Contract Research, Manufacturing & Clinical Trials

Events > Our events

Shaping amorphous solid dispersion

20-Mar-2013
Type:Online conference
Website:Bioavailability Challenge 2013

Creating an Amorphous Solid Dispersion (ASD) is an increasingly popular way of improving Active Pharmaceutical Ingredient (API) solubility. But while the approach can be successful, the big problem is demonstrating ASD stability, preventing ingredients in the amorphous phase becoming (crystallized, and ensuring performance in In-Vivo). In this webinar we will set out the scientific challenges and the cutting edge solutions available in the lab.

Jim Jingjun Huang, Principle Scientist, Hoffmann- La Roche

Moderator: Zachary Brennan, Editor, in-PharmaTechnologist.com and Outsourcing-Pharma.com